Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Follicular Lymphoma. A Combined Analysis on Behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR

BACKGROUND: Allogeneic hematopoietic stem cell transplantation (allo-HCT) remains the only potentially curative treatment option for relapsed follicular lymphoma (FL), yet questions remain on the optimal timing. We have analysed long-term outcomes and associated factors among recipients of allo-HCT...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer
Egile Nagusiak: Sureda, A., Zhang, M.-J., Dreger, P., Carreras, J., Fenske, T., Finel, H., Schouten, H., Montoto, S., Robinson, S., Smith, S. M., Boumedil, A., Hamadani, M., Pasquini, M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5946312/
https://ncbi.nlm.nih.gov/pubmed/29424927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31264
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak